Acadia (ACAD) Up 10% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Acadia Pharmaceuticals (ACAD) . Shares have added about 10% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Acadia due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Acadia Q2 Earnings Beat, Product Sales Drive ...